Case of the month - January 2007 - discussion
Diagnosis - Myofibroblastoma
- A benign spindle cell tumour of the breast stroma composed of myofibroblasts
- Slow growing ranging in size from 1 - 10 cm
- First described by Toker in 1981 in men - subsequently identified in women also
M:F ratio approximately 1:1
- Age range 40 - 90 years
- Similarities between this lesion and both the solitary fibrous tumour and the spindle cell lipoma
The following histological features are recognized:
- Expansile tumour with pushing borders
- Composed of short fascicles of spindle cells with intervening hyalinised collagen bands
- Necrosis absent and mitoses rare
- No entrapment of mammary ducts and lobules within the tumour
- Metaplastic fat or rarely, cartilage, may be found within the tumour
Differential diagnosis:
- Nodular fasciitis
- Inflammatory myofibroblastic tumour
- Fibromatosis
- Benign peripheral nerve sheath tumours
- Haemangiopericytoma
- Leiomyoma
Immunoprofile:
There are differences in accounts on this subject - The WHO volume suggest that
these tumours are invariably and strongly immunoreactive for smooth muscle markers but show variable staining for CD34 and
hormone recptors. Rosen's view is at odds with this and I can recommend his section on this subject which is illustrated with a large number of examples of variant forms (Reference).
Immunoprofile of myofiroblastomas (after Rosen)
Positive |
Variable |
| CD34 |
Smooth Muscle Actin |
| BCL2 |
Desmin |
| ER/PGR |
|
Prognosis:
- These tumours have an excellent prognosis and show no tendency to recurrence after excision.